ARIAD Pharmaceuticals, Inc.
26 Landsdowne Street
Cambridge
Massachusetts
02139
United States
Tel: 617-494-0400
Fax: 617-225-2860
Website: http://www.ariad.com/
About ARIAD Pharmaceuticals, Inc.
ARIAD Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts, is focused on discovering, developing and commercializing precision therapies for patients with rare cancers. ARIAD is working on new medicines to advance the treatment of rare forms of chronic and acute leukemia, lung cancer and other rare cancers. ARIAD utilizes computational and structural approaches to design small-molecule drugs that overcome resistance to existing cancer medicines. http://www.ariad.com or follow ARIAD on Twitter (@ARIADPharm).
526 articles about ARIAD Pharmaceuticals, Inc.
-
Interim Phase 2 Data Show Sustained Clinical Benefit In Advanced Sarcoma Patients Treated With Ariad Pharmaceuticals, Inc.'s mTOR Inhibitor, AP23573
11/16/2005
-
Ariad Pharmaceuticals, Inc. To Webcast Conference Call On AP23573 Clinical Results Presented At The AACR-NCI-EORTC Oncology Conference
11/14/2005
-
New Clinical Data On Ariad Pharmaceuticals, Inc. Novel mTOR Inhibitor, AP23573, To Be Presented At Upcoming Oncology Meetings
11/2/2005
-
Ariad Pharmaceuticals, Inc. Names Chief Commercial Officer To Build Oncology Business
11/1/2005
-
ASCO's Hidden Gems
5/17/2005
-
The Day In Review: Biotech Manages To Contain Its Loss
4/20/2005